HK1055735A1 - Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts - Google Patents
Imidazole derivatives or salts thereof and drugs containing the derivatives or the saltsInfo
- Publication number
- HK1055735A1 HK1055735A1 HK03108049A HK03108049A HK1055735A1 HK 1055735 A1 HK1055735 A1 HK 1055735A1 HK 03108049 A HK03108049 A HK 03108049A HK 03108049 A HK03108049 A HK 03108049A HK 1055735 A1 HK1055735 A1 HK 1055735A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- salts
- derivatives
- drugs containing
- imidazole
- imidazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000194024 | 2000-06-28 | ||
PCT/JP2001/004836 WO2002000648A1 (fr) | 2000-06-28 | 2001-06-08 | Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1055735A1 true HK1055735A1 (en) | 2004-01-21 |
Family
ID=18692919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03108049A HK1055735A1 (en) | 2000-06-28 | 2003-11-06 | Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts |
Country Status (8)
Country | Link |
---|---|
US (1) | US6958353B2 (ko) |
EP (1) | EP1295880A4 (ko) |
KR (1) | KR20030017511A (ko) |
CN (1) | CN1228338C (ko) |
AU (1) | AU2001264223A1 (ko) |
CA (1) | CA2410391A1 (ko) |
HK (1) | HK1055735A1 (ko) |
WO (1) | WO2002000648A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026811A1 (en) * | 2003-05-20 | 2005-02-03 | Mjalli Adnan M. M. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
CN101597262A (zh) * | 2002-03-05 | 2009-12-09 | 特兰斯泰克制药公司 | 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物 |
EP1528921A2 (en) * | 2002-08-02 | 2005-05-11 | Pharmacia Corporation | Methods for treatment and prevention of gastrointestinal conditions |
WO2006113704A2 (en) * | 2005-04-18 | 2006-10-26 | Neurogen Corporation | Subtituted heteroaryl cb1 antagonists |
TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Vtv治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
TW201613878A (en) * | 2014-07-09 | 2016-04-16 | Janssen Pharmaceutica Nv | Pyrazine GPR40 agonists for the treatment of type II diabetes |
KR20200090747A (ko) | 2017-09-12 | 2020-07-29 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 이소프레닐시스테인 카복실 메틸트랜스퍼라제의 억제제로 유용한 화합물 |
IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755526A (en) | 1984-06-18 | 1988-07-05 | Eli Lilly And Company | Method of inhibiting aromatase |
NZ224714A (en) | 1987-06-01 | 1990-03-27 | Janssen Pharmaceutica Nv | Substituted benzotriazole derivatives and pharmaceutical compositions |
CZ141795A3 (en) | 1992-12-02 | 1995-11-15 | Pfizer | 4-substituted catechol diethers as such and for treating diseases and pharmaceutical preparations based thereon |
JPH0733752A (ja) | 1993-07-16 | 1995-02-03 | Sankyo Co Ltd | ジフェニルピラジン誘導体及び除草剤 |
JPH07126256A (ja) | 1993-10-28 | 1995-05-16 | Sankyo Co Ltd | ジフェニルピラジン誘導体および除草剤 |
CA2189068A1 (en) * | 1994-04-27 | 1995-11-02 | Nobuo Mochizuki | Imidazole derivative and process for producing the same |
DE19541146A1 (de) * | 1995-10-25 | 1997-04-30 | Schering Ag | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
AU7674796A (en) * | 1995-11-13 | 1997-06-05 | Eli Lilly And Company | Method for treating anxiety |
US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
JPH11158156A (ja) * | 1997-12-03 | 1999-06-15 | Earth Chem Corp Ltd | 新規な1−(4−アルキルオキシフェニル)イミダゾール化合物 |
SE9904045D0 (sv) * | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
-
2001
- 2001-06-08 EP EP01938563A patent/EP1295880A4/en not_active Withdrawn
- 2001-06-08 WO PCT/JP2001/004836 patent/WO2002000648A1/ja active Application Filing
- 2001-06-08 AU AU2001264223A patent/AU2001264223A1/en not_active Abandoned
- 2001-06-08 KR KR1020027015036A patent/KR20030017511A/ko not_active Application Discontinuation
- 2001-06-08 US US10/258,610 patent/US6958353B2/en not_active Expired - Fee Related
- 2001-06-08 CN CNB018102212A patent/CN1228338C/zh not_active Expired - Fee Related
- 2001-06-08 CA CA002410391A patent/CA2410391A1/en not_active Abandoned
-
2003
- 2003-11-06 HK HK03108049A patent/HK1055735A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1295880A4 (en) | 2004-05-06 |
CN1228338C (zh) | 2005-11-23 |
EP1295880A1 (en) | 2003-03-26 |
KR20030017511A (ko) | 2003-03-03 |
WO2002000648A1 (fr) | 2002-01-03 |
US6958353B2 (en) | 2005-10-25 |
US20030207896A1 (en) | 2003-11-06 |
AU2001264223A1 (en) | 2002-01-08 |
CN1432013A (zh) | 2003-07-23 |
CA2410391A1 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1082249A1 (en) | Isoquinoline derivatives having kinasae inhibitoryactivity and drugs containing the same | |
HUP0105414A3 (en) | Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them | |
EP1216980A4 (en) | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME | |
IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
HK1040995A1 (zh) | 二氧喹啉化合物及其醫藥用途 | |
IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
HUP0301269A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
EP1306387A4 (en) | MEDICAMENTS AND COSMETICS | |
HUP0301230A3 (en) | Phenylpyridazine derivatives and drugs containing the same | |
HUP0101333A3 (en) | Diazepan derivatives and their salts, pharmaceutical compositions containing the same | |
IL157908A0 (en) | Phthalazinone derivatives and pharmaceutical compositions containing the same | |
AU2001269474A1 (en) | Phenylpyridazine Compounds and Medicines Containing the Same | |
IL155937A0 (en) | Imidazole and benzimidazole derivatives and pharmaceutical compositions containing the same | |
HK1043791A1 (en) | Imidazole compounds and medicinal use thereof. | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
IL155736A0 (en) | Pyrimidine derivatives and herbicides containing the same | |
EG23858A (en) | Drug combination | |
HU0001396D0 (en) | 3-amino-3-arylpropan-1-al derivatives and their use | |
GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
HUP0200088A3 (en) | Pyridazin-3-one derivatives and pharmaceutical compositions containing the same | |
AU6475100A (en) | Novel anilide derivatives or salts thereof and drugs containing the same | |
HK1055735A1 (en) | Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts | |
AU2001294240A1 (en) | 2,2-diphenylbutanamide derivatives and medicines containing the same | |
PL349133A1 (en) | Benzamide derivatives and drugs containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: FROM SSP CO., LTD. ? SS?????? TO BIOMEDIX CO., LTD |
|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100608 |